News
Regulators are supposed to abide by society's “bargain” with them: Civil servants are granted lifetime tenure and protected from political pressure and retaliation, and in return, they are supposed to ...
Regulators are supposed to abide by the “bargain” that society has made with them: Civil servants are granted lifetime tenure and are protected from political pressure and retaliation, in return for ...
A major challenge for people who have a form of diabetes is the need to regulate the glucose levels in their body. Normally this is where the body’s insulin-producing cells would respond to glucose ...
The developed technology has been granted two Indian patents, and the findings of the research were published in journals, ...
Researchers at the Indian Institute of Technology (IIT) Guwahati have developed a new method to produce human insulin using a ...
A roundup of the latest biosimilar news from The Center for Biosimilars®. There has been a slew of recent biosimilars news: the steep discounted price of an interchangeable insulin glargine biosimilar ...
Hefei Tianhui Incubator of Technologies Co. Ltd. (HTIT)’s NDA for recombinant human insulin capsule ORMD-0801 for type 2 diabetes is under review by the NMPA and, if approved, is expected to be the ...
Guwahati, have developed a groundbreaking method to produce human insulin using Pseudomonas fluorescens, a safe and efficient ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results